Melissa L Danielson1, Joseph R Holbrook1, Rebecca H Bitsko1, Kimberly Newsome1, Sana N Charania1, Russell F McCord2, Michael D Kogan3, Stephen J Blumberg4. 1. National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA. 2. Center for State, Tribal, Local, and Territorial Support, Centers for Disease Control and Prevention, Atlanta, GA, USA. 3. Maternal and Child Health Bureau, Health Resources and Services Administration, Rockville, MD, USA. 4. National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD, USA.
Abstract
OBJECTIVE: To provide state-level estimates of diagnosed ADHD and associated treatment among children in the United States in 2016 to 2019. METHOD: This study used the National Survey of Children's Health to produce national and state-level estimates of lifetime diagnosis and current ADHD among all children aged 3 to 17 years (n=114,476), and national and state-level estimates of medication and behavioral treatment use among children with current ADHD. RESULTS: The state-level estimates of diagnosed ADHD ranged from 6.1% to 16.3%. Among children with current ADHD, state-level estimates of ADHD medication usage ranged from 37.8% to 81.4%, and state-level estimates of behavioral treatment ranged from 38.8% to 61.8%. CONCLUSION: There was substantial state-level variation for indicators of ADHD diagnosis and associated treatment. These state-level results can be used by policymakers, public health practitioners, health care providers, and other stakeholders to help address the service needs of children with ADHD in their states.
OBJECTIVE: To provide state-level estimates of diagnosed ADHD and associated treatment among children in the United States in 2016 to 2019. METHOD: This study used the National Survey of Children's Health to produce national and state-level estimates of lifetime diagnosis and current ADHD among all children aged 3 to 17 years (n=114,476), and national and state-level estimates of medication and behavioral treatment use among children with current ADHD. RESULTS: The state-level estimates of diagnosed ADHD ranged from 6.1% to 16.3%. Among children with current ADHD, state-level estimates of ADHD medication usage ranged from 37.8% to 81.4%, and state-level estimates of behavioral treatment ranged from 38.8% to 61.8%. CONCLUSION: There was substantial state-level variation for indicators of ADHD diagnosis and associated treatment. These state-level results can be used by policymakers, public health practitioners, health care providers, and other stakeholders to help address the service needs of children with ADHD in their states.
Authors: Jennifer D Parker; Makram Talih; Donald J Malec; Vladislav Beresovsky; Margaret Carroll; Joe F Gonzalez; Brady E Hamilton; Deborah D Ingram; Kenneth Kochanek; Frances McCarty; Chris Moriarity; Iris Shimizu; Alexander Strashny; Brian W Ward Journal: Vital Health Stat 2 Date: 2017-08
Authors: Stephen V Faraone; Philip Asherson; Tobias Banaschewski; Joseph Biederman; Jan K Buitelaar; Josep Antoni Ramos-Quiroga; Luis Augusto Rohde; Edmund J S Sonuga-Barke; Rosemary Tannock; Barbara Franke Journal: Nat Rev Dis Primers Date: 2015-08-06 Impact factor: 52.329
Authors: Brent D Fulton; Richard M Scheffler; Stephen P Hinshaw; Peter Levine; Susan Stone; Timothy T Brown; Sepideh Modrek Journal: Psychiatr Serv Date: 2009-08 Impact factor: 3.084
Authors: Ian Larkin; Desmond Ang; Jonathan Steinhart; Matthew Chao; Mark Patterson; Sunita Sah; Tina Wu; Michael Schoenbaum; David Hutchins; Troyen Brennan; George Loewenstein Journal: JAMA Date: 2017-05-02 Impact factor: 56.272